Search results
Takeda circles a leukemia drug; J.P. Morgan moves into biotech investing
BioPharma Dive via Yahoo Finance· 3 days agoThe Japanese pharma paid $100 million to secure option rights to an Ascentage drug. Elsewhere, J.P....
EU regulator mandates label updates on CAR-T cancer therapies
WHTC 1450 Holland· 3 days ago(Reuters) - The European health regulator said on Friday product information for a class of cancer...
Expert Perspectives on Biggest Court Cases
Law.com· 3 days agoKirkland & Ellis scored a knockout win for Sun Pharmaceutical Industries Ltd. in a more than decadelong multidistrict litigation where the company was accused of conspiring to delay the launch ...
Alumis sets out IPO ambitions to fund TYK2 inhibitor through phase 3 psoriasis trials
FierceBiotech· 7 days agoNot content with bringing in one of the largest private biotech fundraises of 2024 so far, Alumis...
Shift Needed in Research, Treatment, for Aging MS Population
Medscape· 3 days agoFor the first time, the majority of patients with multiple sclerosis (MS) in the United States are,...
Radiopharmaceuticals Are A Buzzy Area For Deal-Making
Crunchbase· 4 days agoWhen reporting on startup investment, big funding rounds and M&A deals for pharmaceutical companies...
Neal Katyal
US News & World Report· 23 hours agoIn December 2017, American Lawyer magazine named him The Litigator of the Year; he was chosen from all the lawyers in the United States. At the age of 54, he has also already argued more Supreme ...
Waters | Wyatt Technology Forms a Strategic Collaboration With Bioz to Promote Scientific Discovery...
Digital Journal· 5 days agoPRESS RELEASE Published June 12, 2024 ACCESSWIRE PALO ALTO, CA / ACCESSWIRE / June 12, 2024 / Bioz, Inc. , a cutting-edge AI software company that is deeply invested in facilitating research ...
Nanoliposomal Irinotecan Fails to Boost Survival in Treated Advanced Biliary Cancer
MedPage Today· 5 days agoNo difference in PFS, median OS favored control group
How to Safely Discontinue Multiple Myeloma Maintenance Care
Medscape· 3 days agoNew research suggested that the key to safely discontinuing multiple myeloma maintenance therapy is...
